CurrentEndo
Get Weekly

Topic · page 65 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 2,561–2,600 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks

    Cohort study

  2. Diabetologia

    The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity

    Mechanistic study

  3. Diabetes Obes Metab

    Time‐in‐range derived from self‐measured blood glucose in people with type 2 diabetes advancing to iGlarLixi : A participant‐level pooled analysis of three phase 3 LixiLan randomized controlled trials

    Meta-analysis

  4. Lancet Diabetes Endocrinol

    Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

    Randomized controlled trial

  5. Lancet Diabetes Endocrinol

    Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

    Meta-analysis

  6. Diabetes Obes Metab

    Evaluating remission of type 2 diabetes using a metabolic intervention including fixed‐ratio insulin degludec and liraglutide: A randomized controlled trial

    Randomized controlled trial

  7. Diabet Med

    Evaluating the impact of differing completion rates of a face‐to‐face DIABETES self‐management education programme on Patient Reported Outcome measures (DIABETES PRO): A feasibility trial protocol

    Trial design

  8. BMJ Open Diabetes Res Care

    Not all healthcare inequities in diabetes are equal: a comparison of two medically underserved cohorts

    Cross-sectional study

  9. Diabetes Obes Metab

    Mediating role of inflammatory biomarkers in the causal effect of body composition on glycaemic traits and type 2 diabetes

    Cohort study

  10. Diabetes Obes Metab

    Glycated haemoglobin variability and risk of renal function decline in type 2 diabetes mellitus: An updated systematic review and meta‐analysis

    Meta-analysis

  11. Cardiovasc Diabetol

    Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT

    Cohort study

  12. Cardiovasc Diabetol

    Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study

    Secondary analysis

  13. Cardiovasc Diabetol

    Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis

    Cohort study

  14. Cardiovasc Diabetol

    Metabolically “extremely unhealthy” obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project

    Cohort study

  15. Cardiovasc Diabetol

    Relationships between ankle blood pressure indices and major adverse cardiovascular events in people with and without type 2 diabetes

    Cohort study

  16. Cardiovasc Diabetol

    Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study

    Cohort study

  17. J Clin Endocrinol Metab

    Weight Loss Differentially Impacts Sex Hormones in Women and Men With Type 2 Diabetes: Look AHEAD Sex Hormone Study

    Randomized controlled trial

  18. Diabetes Obes Metab

    Utilization and cost of non‐insulin glucose‐lowering drugs in Australia from 2013 to 2023

    Cohort study

  19. Diabetes Obes Metab

    Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV

    Secondary analysis

  20. Diabetes Obes Metab

    Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study

    Cohort study

  21. Diabetes Obes Metab

    Efficacy and safety of dapagliflozin add‐on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled study

    Randomized controlled trial

  22. Diabetes Obes Metab

    Glucose‐lowering medicines use before and after entry into long‐term care facilities

    Cohort study

  23. Diabetes Obes Metab

    The association of type 2 diabetes‐related characteristics with fracture risk at different sites

    Cohort study

  24. Diabetes Obes Metab

    The use of composite endpoints in cardiovascular outcome trials for diabetes: A review of 22 randomized clinical trials published since 2008

    Meta-analysis

  25. Diabetes Obes Metab

    Updating and calibrating the Real‐World Progression In Diabetes (RAPIDS) model in a non‐Veterans Affairs population

    Diagnostic or prognostic study

  26. Lancet Diabetes Endocrinol

    Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident cases from 31 cohorts in 20 countries

    Meta-analysis

  27. Cardiovasc Diabetol

    Comparative effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on heart failure with preserved ejection fraction in diabetic patients: a meta-analysis

    Meta-analysis

  28. Cardiovasc Diabetol

    Impaired glucose metabolism and the risk of vascular events and mortality after ischemic stroke: A systematic review and meta-analysis

    Meta-analysis

  29. Cardiovasc Diabetol

    The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study

    Cohort study

  30. Diabetes Obes Metab

    Adherence to glucagon‐like peptide ‐1 receptor agonist treatment in type 2 diabetes mellitus: A nationwide registry study

    Cohort study

  31. J Clin Endocrinol Metab

    Low C-Reactive Protein Alleles in Hepatocyte Nuclear Factor 1A Are Associated With an Increased Risk of Cardiovascular Disease

    Meta-analysis

  32. BMJ Open Diabetes Res Care

    Ethnic differences in the manifestation of early-onset type 2 diabetes

    Cross-sectional study

  33. BMJ Open Diabetes Res Care

    Adipose tissue–derived adipsin marks human aging in non-type 2 diabetes population

    Cross-sectional study

  34. Lancet Diabetes Endocrinol

    Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore

    Cross-sectional study

  35. Int J Obes (Lond)

    Tirzepatide outcompetes long-acting insulin in managing type 2 diabetes: a meta-analysis of three phase 3 randomized controlled trials

    Meta-analysis

  36. Diabetes Care

    Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C)

    Cohort study

  37. Diabetologia

    Effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease

    Cohort study

  38. Diabetes Obes Metab

    Optimizing physician‐encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study

    Research article

  39. Cardiovasc Diabetol

    Causal associations between insulin and Lp(a) levels in Caucasian population: a Mendelian randomization study

    Research article

  40. BMJ Open Diabetes Res Care

    Combined impact of heat and dust on diabetes hospitalization in Kuwait

    Research article

All 4,758 Briefs in ExploreShowing Briefs 2,561–2,600 of 4,758, newest first